Abdominal aortic aneurysm, Ch 6

Abortion

D incompatibility/isoimmunization, Ch 38

induced. See Induced abortion

ABR (auditory brainstem response) test, Ch 35

Absorptiometry, osteoporosis screening, Ch 46

Abstinence, sexual, Ch 62

genital herpes simplex and, Ch 30

Accidents. See Injuries

Acquired immune deficiency syndrome (AIDS). See Human immunodeficiency virus

Acyclovir, Ch 30

Adolescent idiopathic scoliosis, Ch 47

Adolescents and young adults

alcohol use, Ch 52

asymptomatic bacteriuria, Ch 31

blood pressure screening, Ch 3

cervical cancer, Ch 9

chlamydial infection, Ch 29

cholesterol levels, Ch 2

contraception, Ch 63

coronary heart disease, Ch 1

depression, Ch 49

genital herpes simplex, Ch 30

gonorrhea, Ch 27

hearing impairment, Ch 35

hemoglobinopathy screening, Ch 43

HIV infection, Ch 28, Ch 62

idiopathic scoliosis, Ch 47

illicit drug use, Ch 53

immunization recommendations, Ch 65, Ch 66

injury risk

family violence, Ch 51

household and recreational, Ch 58

motor vehicle, Ch 57

youth violence, Ch 59

iron deficiency anemia, Ch 22

nutritional needs, Ch 56

obesity, Ch 21

rubella, Ch 32

sexually transmitted diseases, Ch 62

skin cancer, Ch 12

smoking prevention, Ch 54

suicide, Ch 49, Ch 50

syphilis, Ch 26

testicular cancer, Ch 13

thyroid disease, Ch 20

tuberculous infection, Ch 25

unintended pregnancy, Ch 63

violence prevention counseling, Ch 59

visual impairment, Ch 33

Affective disorder. See Depression

AIDS (acquired immune deficiency syndrome), Ch 28. See also Human immunodeficiency virus

Air bags, Ch 57

Alcohol consumption, Ch 52

blood cholesterol, Ch 2

dental and periodontal disease, Ch 61

hypertension, Ch 3

injury risk

household and recreational, Ch 58

motor vehicle, Ch 57

youth violence, Ch 59

oral cancer, Ch 16

during pregnancy, Ch 52

suicide risk, Ch 50

tuberculous infection and, Ch 25

violence associated with, Ch 59

Alcoholism, Ch 52

Alcohol Use Disorders Identification Test (AUDIT), Ch 52

Allen picture cards visual acuity test, 

Ch 33

a-fetoprotein. See Maternal serum 

a-fetoprotein; Testicular cancer

Alzheimer's disease, Ch 48

Amantadine, for influenza A prophylaxis, Ch 66

Amblyopia, Ch 33

Amniocentesis

D incompatibility and, Ch 38

Down syndrome screening, Ch 41

hemoglobinopathy screening, Ch 43

neonatal complications, Ch 41, Ch 42

neural tube defects, Ch 42

phenylketonuria diagnosis, Ch 44

sickle sell disease, Ch 43

thalassemia screening, Ch 43

Amsler grid, retinal detachment detection, Ch 33

Anabolic steroid use, Ch 53

Anemia

D incompatibility and, Ch 38

iron deficiency. See Iron deficiency anemia

sickle cell, Ch 43

thalassemia and, Ch 43

Anencephaly, Ch 42

Aneuploidy, Ch 41

Aneurysm, abdominal aortic. See Abdominal aortic aneurysm

Angiotensin II infusion test, preeclampsia and, Ch 37

Anti-HBc (hepatitis B core antigen antibody), Ch 24

Antiplatelet drug therapy

for carotid artery stenosis, Ch 4

for peripheral arterial disease, Ch 5

Anti-tobacco messages, Ch 54

Aortic aneurysm, abdominal. See Abdominal aortic aneurysm

Apolipoproteins, familial hypercholesterolemia and, Ch 2

Asphyxia, perinatal. See Perinatal morbidity/mortality

Asphyxiation, prevention counseling for elderly persons, Ch 58

Aspiration of food, prevention counseling, Ch 58

Aspirin prophylaxis

cerebrovascular disease, Ch 4

colorectal cancer prevention, Ch 8

myocardial infarction prevention, 

Ch 69

in pregnancy, Ch 70

vascular dementia, Ch 48

Asymptomatic bacteriuria, Ch 31

Asymptomatic carotid artery stenosis. See Carotid artery stenosis

Asymptomatic person, defined, Ch ii

Atherosclerosis. See also Cardiovascular diseases

carotid artery stenosis, Ch 4

cholesterol screening, Ch 2

coronary heart disease, Ch 1

peripheral arterial disease, Ch 5

Atrial fibrillation

cerebrovascular disease, Ch 4

hyperthyroidism, Ch 20

ATV injuries, Ch 58

Audiometry, Ch 35

AUDIT (Alcohol Use Disorders Identification Test), Ch 52

Auditory brainstem response testing, Ch 35

Auditory response cradle, Ch 35

Axial rotation deviations, Ch 47

AZT (zidovudine), Ch 28

Bacille Calmette-Gurin vaccine, Ch 25

Back belts, low back pain prevention, 

Ch 60

Back pain

adolescent idiopathic scoliosis, Ch 47

low, prevention counseling, Ch 60

Bacteriuria, asymptomatic, Ch 31

Barium enema, colorectal cancer screening, Ch 8

Barrier contraception, Ch 63

chlamydial infection and, Ch 29

genital herpes simplex and, Ch 30

sexually transmitted disease and, Ch 62

Basal cell carcinoma, Ch 12

BCG (Bacille Calmette-Gurin) vaccine, Ch 25

Beck Depression Inventory, Ch 49

Behavioral testing, for infant hearing impairment, Ch 35

b-carotene, oral cancer and, Ch 16

Bicycling injuries, prevention counseling, Ch 58

Binge drinking, Ch 52

Biochemical markers, bone turnover, Ch 46

Bioelectrical impedance, obesity screening, Ch 21

Birth, premature. See Premature birth

Birth control. See Contraceptive methods

Bladder cancer, Ch 17

Blindness. See also Visual impairment; Glaucoma

diabetes mellitus, Ch 19

gonococcal ophthalmia neonatorum, Ch 27

Blood pressure, elevated. See Hypertension

Blood typing, for D incompatibility, Ch 38

Body mass index, Ch 21

Body weight/height tables, obesity screening, Ch 21

Bone mineral density

osteoporosis screening, Ch 46

thyroid replacement therapy and, 

Ch 20

Brainstem response testing, auditory, 

Ch 35

Breast cancer, Ch 7

colorectal cancer and, Ch 8

hormone therapy and, Ch 68

obesity and, Ch 21

ovarian cancer and, Ch 14

Breast examination, Ch 7

Breastfeeding, Ch 56

HIV infection risk, Ch 28

infant dental disease, Ch 61

iron deficiency anemia, Ch 22

ovarian cancer risk reduction, Ch 64

postpartum rubella vaccination, Ch 32

BSE (breast self-examination), Ch 7

Burden of suffering, Ch ii

Burns, prevention counseling, Ch 58

Caesarean delivery. See Cesarean delivery

CAGE screening instrument, Ch 52

Calcium

in healthy diet, Ch 56

osteoporosis prophylaxis, Ch 46

preeclampsia prophylaxis, Ch 37

Cancer. See also specific sites

nutritional factors, Ch 56

Car seats, Ch 57

Carbohydrates, in healthy diet, Ch 56

Carcinoembryonic antigen. See Serum tumor markers

Cardiac disorders. See Cardiovascular diseases

Cardiotocography, Ch 39

Cardiovascular diseases. See also Coronary heart disease; Cholesterol, blood; Hypertension

abdominal aortic aneurysm, Ch 6

cartoid artery stenosis, Ch 4

diabetes mellitus, Ch 19

elevated lead levels, Ch 23

exercise-induced, Ch 55

hypertension, Ch 3

obesity, Ch 21

peripheral arterial disease, Ch 5

postmenopausal hormone prophylaxis, Ch 68

syphilis, Ch 26

thyroid disease, Ch 20

Carotid artery stenosis, Ch 4. See also Cardiovascular diseases; Cerebrovascular disease

Carotid bruit auscultation, Ch 4

Carotid duplex sonography, Ch 4

Case-control study, Ch ii

Cataracts, Ch 33

CBE (clinical breast examination), Ch 7

Ceftriaxone prophylaxis, Ch 67

Center for Epidemiologic Studies Depression Scale (CES-D), Ch 49

Cerebrovascular disease

aspirin prophylaxis, Ch 69

carotid artery stenosis, Ch 4

dementia, Ch 48

diabetes mellitus, Ch 19

hypertension, Ch 3

postmenopausal hormone prophylaxis, Ch 68

tobacco use, Ch 54

Cervical bruit. See Carotid bruit auscultation

Cervical cancer, Ch 9

human immunodeficiency virus, Ch 28

obesity, Ch 21

risk reduction, Ch 64

Cervical cap, Ch 63

sexually transmitted disease risk reduction, Ch 62

Cervicography, Ch 9

Cesarean delivery

fetal a-thalassemia, Ch 43

genital herpes simplex, Ch 30

HIV infection, Ch 28

intrapartum electronic fetal monitoring, Ch 39

malpresentations, Ch 36

maternal morbidity/mortality, Ch 30

multiple gestation, Ch 36

neural tube defects, Ch 42

neonatal complications, Ch 30, Ch 39

scalp blood sampling, Ch 39

CES-D (Center for Epidemiologic Studies Depression Scale), Ch 49

Chest x-ray

lung cancer, Ch 11

tuberculous infection, Ch 25

Chickenpox. See Varicella entries

Child abuse, Ch 51

Childbirth, fetal monitoring during, Ch 39

Children. See also Adolescents; Infants

asymptomatic bacteriuria, Ch 31

BCG vaccine, Ch 25

child abuse, Ch 51

cholesterol levels, Ch 2

coronary heart disease, Ch 1

dental disease, Ch 61

depression, Ch 49

development. See Growth and developmental patterns, in children

Down syndrome. See Down syndrome

growth. See Growth and developmental patterns, in children

hearing impairment, Ch 35

hemoglobinopathies, Ch 43

hepatitis B, Ch 24

HIV infection, Ch 28

hypertension, Ch 3

hypothyroidism, congenital, Ch 45

illicit drug use, Ch 53

immunization recommendations, Ch 65

injury risk

household and recreational, Ch 58

motor vehicle, Ch 57

iron deficiency anemia, Ch 22

lead levels, Ch 23

low birth weight. See Low birth weight

neural tube defects, Ch 42

nutritional needs, Ch 56

obesity, Ch 21

Children_continued

ophthalmia neonatorum. See Ophthalmia neonatorum

phenylketonuria, Ch 44

perinatal mortality. See Perinatal morbidity/mortality

prematurity. See Premature birth

scoliosis, Ch 47

sickle cell disease, Ch 43

skin cancer prevention, Ch 12

smoking prevention, Ch 54

testicular cancer, Ch 13

thyroid dysfunction, Ch 20

tuberculous infection, Ch 25

urinary tract abnormalities, Ch 31

visual impairment, Ch 33

violence. See Child abuse

Child safety seats and restraints, Ch 57

Chlamydial infection, Ch 29

gonorrhea and, Ch 27

prevention counseling, Ch 62

Chlamydial ophthalmia neonatorum. See under Ophthalmia neonatorum

Chlamydia trachomatis infection. See Chlamydial infection

Cholesterol, blood, Ch 2

carotid atherosclerosis, Ch 4

coronary heart disease and, Ch 1

obesity, Ch 21

peripheral arterial disease, Ch 5

postmenopausal hormone prophylaxis, Ch 68

thyroxine treatment, Ch 20

Chorionic villus sampling

D incompatibility, Ch 38

Down syndrome, Ch 41

versus amniocentesis, Ch 41

fetal morbidity/mortality, Ch 41

hemoglobinopathy screening, Ch 43

phenylketonuria diagnosis, Ch 44

sickle cell disease diagnosis, Ch 43

Chromosome anomalies. See Down syndrome

Cigarette smoking, Ch 54. See also Tobacco use

Clinical breast examination, Ch 7

Clinician, defined, Ch ii

Clock Drawing Test, Ch 48

Clonidine, smoking cessation aid, Ch 54

Cobb angle, adolescent idiopathic scoliosis and, Ch 47

Cocaine use, Ch 53. See also Drug abuse

Cognitive function, dementia and, Ch 48

Cohort study, Ch ii

Coitus interruptus, Ch 63

Colonoscopy, Ch 8

Colorectal cancer, Ch 8

diet and, Ch 56

obesity and, Ch 21

Color vision assessment, Ch 33

Colposcopy, Ch 9

Compliance, Ch iv

Computed tomography

abdominal aortic aneurysm, Ch 6

osteoporosis, Ch 46

pancreatic cancer, Ch 15

Condom use

contraceptive method, Ch 63. See also Barrier contraception

sexually transmitted disease prevention, Ch 62

Conductive hearing loss, Ch 35

Confidentiality

HIV infection testing, Ch 28

illicit drug use testing, Ch 53

Conflict resolution, Ch 59

Congenital anomalies

congenital hearing loss and, Ch 35

diabetes mellitus and, Ch 19

heart defects, Ch 1, Ch 41, Ch 44

hearing loss, Ch 35

folic acid/folate prophylaxis, Ch 42

maternal serum a-fetoprotein, Ch 42

neural tube defects, Ch 42

transverse limb reduction, chorionic villus sampling and, Ch 41

ultrasonographic detection, Ch 36

Congenital hypothyroidism, Ch 45

Congenital malformation. See Congenital anomalies

Congenital rubella syndrome, Ch 32

Congenital syphilis, Ch 26

Conjunctivitis, neonatal. See Ophthalmia neonatorum

Contact tracing

chlamydial infection, Ch 29

gonorrhea, Ch 27

hepatitis B, Ch 24

HIV infection, Ch 28

syphilis, Ch 26

tuberculous infection, Ch 25

Contraceptive methods, Ch 63. See individual methods

barrier. See Barrier contraception

hormone preparations. See Oral contraceptives

Contraceptive sponge, Ch 62, Ch 63

Controlled trial, Ch ii

Coombs test, Ch 38

Coronary artery disease. See Coronary heart disease

Coronary heart disease, Ch 1

alcohol and risk of, Ch 52

cerebrovascular disease, Ch 4

diabetes mellitus, Ch 19

exercise benefits, Ch 55

high blood cholesterol, Ch 2

hypertension, Ch 3

nutritional factors, Ch 56

obesity, Ch 21

peripheral arterial disease, Ch 5

postmenopausal hormone prophylaxis, Ch 68

thyroxine replacement therapy, Ch 20

tobacco use, Ch 54

Correctional institutions

chlamydial infection in, Ch 29

HIV infection in, Ch 28

rubella outbreaks in, Ch 32

Corsets, low back pain prevention, Ch 60

Cost/cost-effectiveness, of preventive services, Ch v

abdominal aortic aneurysm, Ch 6

blood cholesterol, Ch 2

breast cancer, Ch 7

carotid artery stenosis, Ch 4

cervical cancer, Ch 9

chlamydial infection, Ch 29

colorectal cancer, Ch 8

congenital hypothyroidism, Ch 45

coronary heart disease, Ch 1

D immunoglobulin prophylaxis, Ch 38

gestational diabetes mellitus, Ch 19

hemoglobinopathies, Ch 43

hepatitis B, Ch 24

HIV infection, Ch 28

home uterine activity monitoring, 

Ch 40

immunization

adult, Ch 66

childhood, Ch 65

iron deficiency anemia, Ch 22

lead levels, Ch 23

lung cancer, Ch 11

obesity, Ch 21

ovarian cancer, Ch 14

pancreatic cancer, Ch 15

postmenopausal hormone prophylaxis, Ch 68

prenatal phenylketonuria screening, Ch 44

prostate cancer, Ch 10

rubella, Ch 32

skin cancer, Ch 12

syphilis, Ch 26

testicular cancer, Ch 13

thyroid disease, Ch 20

Counseling interventions, Ch iv

aspirin prophylaxis

myocardial infarction, Ch 69

in pregnancy, Ch 70

dementia, Ch 48

dental and periodontal disease, Ch 61

Down syndrome, Ch 41

exercise promotion, Ch 55

genital herpes simplex, Ch 30

gynecologic cancer, Ch 64

hearing aid devices, Ch 35

hemoglobinopathies, Ch 43

hepatitis B, Ch 24

high blood cholesterol, Ch 2

HIV infection, Ch 28, Ch 62

household injury, Ch 58

hypertension, Ch 3

iron deficiency anemia, Ch 22

lead levels, Ch 23

low back pain, Ch 60

motor vehicle injury, Ch 57

neural tube defects, Ch 42

obesity, Ch 21

oral cancer, Ch 16

osteoporosis, Ch 46

ovarian cancer, Ch 64

pancreatic cancer, Ch 15

peripheral arterial disease, Ch 5

postmenopausal hormone prophylaxis, Ch 46, Ch 68

recreational injury, Ch 58

sexually transmitted disease, Ch 62

skin cancer, Ch 12

suicide risk, Ch 50

testicular cancer, Ch 13

tobacco use, Ch 54

unintended pregnancy, Ch 63

youth violence, Ch 59

Cover test, Ch 33

"Crack" cocaine. See Drug abuse

Cretinism, Ch 45

Crib-o-gram, Ch 35

CT. See Computed tomography

Cystadenocarcinoma antigen. See Serum tumor markers

Cystoscopy, bladder cancer and, Ch 17

Cytology. See also Papanicolaou test

genital herpes simplex screening, Ch 30

sputum, lung cancer and, Ch 11

urine, bladder cancer and, Ch 17

D immunoglobulin prophylaxis, Ch 38

D incompatibility, Ch 38

Danazol, postcoital administration, Ch 63

Delivery, premature. See Premature birth

Dementia, Ch 48

Dental disease

nutritional factors, Ch 56

oral cancer screening, Ch 16

prevention, Ch 61

Depo-Provera, Ch 63

Depot-medroxyprogesterone acetate, Ch 63

Depression, Ch 49

dementia and, Ch 48

Depression_continued

hearing impairment, Ch 35

low back pain risk, Ch 60

postpartum, thyroid dysfunction and, Ch 20

suicide risk, Ch 50

DFA. See Direct fluorescent antibody

Diabetes mellitus, Ch 19

asymptomatic bacteriuria, Ch 31

carotid artery stenosis, Ch 4

coronary heart disease, Ch 1

exercise benefits, Ch 55

glaucoma, Ch 34

neural tube defects, Ch 42

obesity, Ch 21

pancreatic cancer, Ch 15

peripheral arterial disease, Ch 5

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Ch 49

Diagnostic Interview Schedule, depression screening, Ch 49

Diaphragm

barrier contraceptive method, Ch 63

sexually transmitted disease risk reduction, Ch 62

Dietary factors. See Diet therapy; Nutrition

Diet therapy. See also Nutrition; Weight control

cholesterol reduction, Ch 2

in diabetes mellitus, Ch 19

in hypertension, Ch 3

in obesity, Ch 21

in phenylketonuria, Ch 44

Digital rectal examination

colorectal cancer, Ch 8

prostate cancer, Ch 10

Diphtheria

adult immunization, Ch 66

childhood immunization, Ch 65

Diphtheria-pertussis-tetanus vaccine

with acellular pertussis component (DPaT vaccine), Ch 65

in childhood, Ch 65

postexposure tetanus prophylaxis, 

Ch 67

Diphtheria-tetanus vaccine, Ch 67

Dipstick urinalysis

asymptomatic bacteriuria, Ch 31

bladder cancer, Ch 17

chlamydial infection, Ch 29

diabetes mellitus, Ch 19

gonorrhea, Ch 27

preeclampsia, Ch 37

Dipyridamole/aspirin therapy, Ch 4

Direct fluorescent antibody

chlamydial infection screening, Ch 29

genital herpes simplex screening, Ch 30

Disc photography, glaucoma screening, Ch 34

Distraction testing, infant hearing impairment, Ch 35

DNA analysis

fetal blood type, Ch 38

hemoglobinopathy screening, Ch 43

phenylketonuria prenatal diagnosis, 

Ch 44

DNA hybridization tests

chlamydial infection screening, Ch 29

genital herpes simplex screening, 

Ch 30

gonorrhea screening, Ch 27

Domestic violence, Ch 51

Doppler ultrasound. See also Ultrasonography

ankle-arm pressure ratios, Ch 5

intrapartum fetal monitoring, Ch 39

transvaginal color-flow, ovarian cancer and, Ch 14

Down syndrome, Ch 41

thyroid dysfunction and, Ch 20

DPaT vaccine. See Diphtheria-pertussis-tetanus vaccine

DPT vaccine. See Diphtheria-pertussis-tetanus vaccine

DRE. See Digital rectal examination

Drowning, prevention counseling, Ch 58

Drug abuse, Ch 53. See also Injection drug users

injury risk

household and recreational, Ch 58

motor vehicle, Ch 57

sexually transmitted disease risk, Ch 62

suicide risk, Ch 50

violence associated with, Ch 59

Drug overdose. See also Drug abuse

suicide, Ch 50

DSM-IV (Diagnostic and Statistical Manual of Mental Disorders), Ch 49

DT vaccine, Ch 67

Dual energy x-ray absorptiometry (DXA), Ch 46

Dual photon absorptiometry (DPA), 

Ch 46

ECG. See Electrocardiography

Eclampsia. See preeclampsia/eclampsia

EDTA lead mobilization test, Ch 23

Education. See Counseling interventions

Effectiveness criteria, preventive services, Ch ii

EIA. See Enzyme immunoassay

Elder abuse, Ch 51

Elderly persons

abdominal aortic aneurysm, Ch 6

abuse and neglect, Ch 51

antihypertensive therapy, Ch 3

asymptomatic bacteriuria, Ch 31

bladder cancer, Ch 17

breast cancer, Ch 7

carotid artery stenosis, Ch 4

cervical cancer, Ch 9

colorectal cancer, Ch 8

coronary heart disease, Ch 1

dementia, Ch 48

glaucoma, Ch 34

hearing impairment, Ch 35

high blood cholesterol, Ch 2

immunizations

influenza A, Ch 66

pneumococcal disease, Ch 66

injury prevention counseling, Ch 58

iron deficiency anemia, Ch 22

nutritional needs, Ch 56

oral cancer, Ch 16

pancreatic cancer, Ch 15

prostate cancer, Ch 10

suicide, Ch 50

thyroid disease, Ch 20

tuberculous infection, Ch 25

urinary tract infections, Ch 31

visual impairment, Ch 33

Electrocardiography

coronary artery disease, Ch 1

intrapartum fetal monitoring, Ch 39

Electronic monitoring, of fetal heart rate. See Intrapartum electronic fetal monitoring

Electrophysiologic testing, infant hearing impairment, Ch 35

Elevated lead levels, Ch 23

Encephalocele, Ch 42

Endocervical brush, Ch 9

Endometrial cancer

colorectal cancer and, Ch 8

hormone therapy and, Ch 68

obesity, Ch 21

risk reduction, Ch 64

Endometritis. See Pelvic inflammatory 

disease

Endoscopy

colorectal cancer, Ch 8

pancreatic cancer, Ch 15

Enzyme immunoassay (EIA)

chlamydial infection, Ch 29

genital herpes simplex, Ch 30

gonorrhea, Ch 27

HIV infection, Ch 28

illicit drug use, Ch 53

rubella susceptibility, Ch 32

EOE (evoked otoacoustic emission) testing, Ch 35

Erythrocyte protoporphyrin test

elevated lead levels, Ch 23

iron deficiency anemia, Ch 22

Erythrocyte rosette test, Ch 38

Erythroplakia, oral cancer and, Ch 16

Estriol, unconjugated, Ch 41

Estrogen. See also Estrogen replacement therapy

coronary heart disease, Ch 2

high blood cholesterol, Ch 2

oral contraception, Ch 63

postcoital administration, Ch 63

Estrogen replacement therapy, Ch 68

osteoporosis prophylaxis, Ch 46

Ethylenediaminetetraacetic acid (EDTA), Ch 23

Evoked otoacoustic emission testing, Ch 35

Exercise, Ch 55

adolescent idiopathic scoliosis, Ch 47

counseling to promote, Ch 55

diabetes mellitus, Ch 19

falls prevention, Ch 58

high blood cholesterol, Ch 2

hypertension, Ch 3

iron deficiency anemia, Ch 22

low back pain prevention, Ch 60

obesity, Ch 21

osteoporosis, Ch 46

peripheral arterial disease, Ch 5

Falls, prevention, Ch 58

Familial atypical mole and melanoma syndrome, Ch 12

Familial combined hyperlipidemia, Ch 2

Familial hypercholesterolemia, Ch 2

Familial polyposis, colorectal cancer and, Ch 8

Family planning clinics, Ch 63

Family violence, Ch 51

FAM-M syndrome, Ch 12

Fat, in healthy diet, Ch 56

FCH (familial combined hyperlipidemia), Ch 2

Fecal occult blood test, Ch 8

Ferritin, iron deficiency anemia screening and, Ch 22

Fetal alcohol syndrome, Ch 52

Fetal distress, Ch 39

Fetal heart rate, Ch 39

Fetal malformation. See Congenital anomalies

Fetal monitoring, Ch 39

Fetal morbidity/mortality. See also

Perinatal morbidity/mortality

amniocentesis, Ch 41, Ch 42

chorionic villus sampling, Ch 41

chronic hypertension, Ch 37

congenital syphilis, Ch 26

D incompatibility, Ch 38

Fetal morbidity/mortality_continued

hydrops

preeclampsia/eclampsia, Ch 37

a-thalassemia, Ch 43

hypoxia, Ch 39

intrauterine growth retardation, Ch 36

maternal bacteriuria, Ch 31

maternal serum a-fetoprotein, Ch 42

preeclampsia, Ch 37

Fetal scalp blood, intrapartum monitoring, Ch 39

FH (familial hypercholesterolemia), Ch 2

Fiber, in healthy diet, Ch 56

Finger rub tests, hearing impairment, Ch 35

Firearms

unintentional injuries, Ch 58

suicide risk, Ch 50

violence and, Ch 59

Fires, prevention counseling, Ch 58

Flossing, dental, Ch 61

Fluorescence polarization immunoassay, Ch 53

Fluorescent treponemal antibody absorption (FTA-ABS), Ch 26

Fluoridation, dental disease prevention, Ch 61

Folic acid/folate prophylaxis, Ch 42

Forward-bending test, Ch 47

Fractures

dietary calcium and, Ch 56

falls prevention and, Ch 58

osteoporosis, Ch 46

postmenopausal hormone prophylaxis, Ch 68

Free-field voice test, hearing impairment, Ch 35

Free thyroxine index, Ch 20

FTA-ABS (fluorescent treponemal antibody absorption), Ch 26

FTI (free thyroxine index), Ch 20

Functional Activities Questionnaire, Ch 48

Functional assessment, dementia screening, Ch 48

Funduscopy

macular degeneration, Ch 33

glaucoma, Ch 34

Gait disorders, falls risk, Ch 58

Genital herpes simplex, Ch 30

Genital lesions/ulcerations

herpes simplex virus, Ch 30

primary syphilis, Ch 26

German measles. See Rubella

Gestational age

maternal serum a-fetoprotein, Ch 42

ultrasonographic determination, Ch 36

Gestational diabetes, Ch 19

GGT (g-glutamyl transferase), alcoholism screening, Ch 52

Gingivitis, Ch 61

Glaucoma, Ch 34

Glucose challenge test, gestational diabetes, Ch 19

Glucose, plasma or blood, Ch 19

Glucose tolerance test, Ch 19

Glucosuria, Ch 19

Glycosylated protein assays, Ch 19

Gonorrhea, Ch 27. See also Ophthalmia neonatorum

Grating visual acuity cards, Ch 33

Growth and developmental patterns, in children. See also Obesity

iron deficiency anemia, Ch 22

speech and language, Ch 35

Guaiac-impregnated cards, Ch 8

Gums, disease prevention, Ch 61

Gun possession. See Firearms

Guthrie test, phenylalanine determination, Ch 44

Gynecologic cancers. See also specific cancers

prevention counseling, Ch 64

Haemophilus influenzae type b disease

postexposure prophylaxis, Ch 67

vaccine in childhood, Ch 65

Harmful drinking, Ch 52

HATTS (hemagglutination treponemal test for syphilis), Ch 26

Hazardous drinking, Ch 52

HBIG (hepatitis B immune globulin)

postexposure prophylaxis, Ch 67

prenatal HBsAg testing and, Ch 24

HBsAg (hepatitis B surface antigen), 

Ch 24

HDCV (human diploid cell vaccine). See Rabies

HDL-C (high-density lipoprotein cholesterol), Ch 2

Health care workers

immunizations, Ch 66

postexposure prophylaxis, Ch 67

tuberculous infection screening, Ch 25

Health examination, age-specific, Ch iii

Hearing aids, Ch 35

Hearing impairment, Ch 35

Hemagglutination treponemal test for syphilis, Ch 26

Hematocrit, Ch 22

Hematuria, bladder cancer and, Ch 17

Hemodialysis and hepatitis B, Ch 24

Hemoglobin

electrophoresis, Ch 43

glycosylated, Ch 19

iron deficiency anemia and, Ch 22

Hemoglobin E trait, Ch 43

Hemoglobinopathies, Ch 43

Hemoglobin S, Ch 43

Hemolytic disease, D incompatibility, 

Ch 38

Hepatitis A

immunization against

adult, Ch 66

childhood, Ch 65

postexposure prophylaxis, Ch 67

Hepatitis B, Ch 24

postexposure prophylaxis, Ch 24, Ch 67

risks, Ch 24

sexual transmission, Ch 62

vaccine. See Hepatitis B vaccine

Hepatitis B core antigen antibody (anti-HBc), Ch 24

Hepatitis B immune globulin, Ch 24, Ch 67

Hepatitis B surface antigen (HBsAg), Ch 24

Hepatitis B vaccine

immunization

adult, Ch 66

childhood, Ch 65

HIV infection and, Ch 28

in infancy, Ch 24

postexposure prophylaxis, Ch 24, Ch 67

prevaccination screening, Ch 24

Hepatitis delta virus, Ch 66

Hereditary nonpolyposis colorectal cancer, Ch 8

Hereditary ovarian cancer syndrome, 

Ch 14

Heroin, Ch 53. See also Drug abuse; Injection drug users

Herpes simplex virus

congenital hearing loss, Ch 35

genital, Ch 30, Ch 62

Hib vaccine, Ch 65

High blood cholesterol, Ch 2. See also Cholesterol; Lipid abnormalities

High blood pressure. See Hypertension

High-density lipoprotein cholesterol (HDL-C), Ch 2

High performance liquid chromatography, Ch 43

High-risk register, Ch 35

HI (hemagglutination-inhibition) antibody, Ch 32

Hip fractures. See Fractures

Hip protectors, Ch 58

HIV. See Human immunodeficiency virus

Holter monitoring, Ch 1

Homeless persons

HIV infection, Ch 28

tuberculous infection, Ch 25

Home uterine activity monitoring, Ch 40

Homicide, Ch 51, Ch 59

Hormonal therapy, postmenopausal, 

Ch 68. See also Estrogen

Household injuries, prevention counseling, Ch 58. See also Injuries

HPV (human papilloma virus), Ch 9, 

Ch 62, Ch 64

HRIG (human rabies immune globulin), Ch 67

HSV. See Herpes simplex virus

HUAM (home uterine activity monitoring), Ch 40

Human chorionic gonadotropin

Down syndrome, Ch 41

testicular cancer, Ch 13

Human diploid cell vaccine. See Rabies

Human immunodeficiency virus, Ch 28

cervical cancer, Ch 9

dementia, Ch 48

D immunoglobulin, Ch 38

gonorrhea co-infection, Ch 27

illicit drug use. See Injection drug users

oral cancer, Ch 16

prevention counseling, Ch 62

syphilis co-infection, Ch 26

tuberculous co-infection, Ch 25

Human papilloma virus, Ch 9, Ch 62, 

Ch 64

Human rabies immune globulin, Ch 67

Hydrops, fetal or neonatal

D incompatibility, Ch 38

preeclampsia/eclampsia, Ch 37

Hypercholesterolemia. See Cholesterol

Hyperglycemia. See Diabetes mellitus

Hyperphenylalaninemia, maternal, Ch 44

Hypertension, Ch 3

abdominal aortic aneurysm, Ch 6

asymptomatic bacteriuria, Ch 31

carotid artery stenosis, Ch 4

coronary heart disease, Ch 1

elevated lead levels, Ch 23

exercise benefits, Ch 55

gestational diabetes, Ch 19

glaucoma, Ch 34

high blood cholesterol, Ch 2

obesity, Ch 21

ocular, Ch 34

peripheral arterial disease, Ch 5

pregnancy-associated

aspirin prophylaxis trials, Ch 70

preeclampsia. See Preeclampsia/eclampsia

urinary tract abnormalities in infants and children, Ch 31

vascular dementia, Ch 48

Hyperthyroidism, Ch 20

Hypertrophy, benign prostatic, Ch 10

Hypothyroidism, Ch 20

congenital, Ch 45

dementia and, Ch 48

Down syndrome and, Ch 20

Hypoxia, intrauterine, Ch 39

preeclampsia and, Ch 37

IDUs. See Injection drug users

IFA (immunofluorescence assay), HIV infection screening, Ch 28

IgA. See Immunoglobulin A

IGT (impaired glucose tolerance), Ch 19

Illicit drugs, Ch 53. See also Drug abuse

Immigrants

hepatitis B infection, Ch 24

HIV infection, Ch 28

iron deficiency anemia, Ch 22

tuberculous infection, Ch 25

Immune globulin

against hepatitis A, Ch 66, Ch 67

against hepatitis B, Ch 24, Ch 66, Ch 67

against rabies, Ch 67

against tetanus, Ch 67

Immunizations. See also Vaccines

adult, Ch 66

childhood, Ch 65

postexposure prophylaxis, Ch 67

Immunoassay. See Enzyme immunoassay; Radioimmune assay

Immunofluorescence assay, HIV infection screening, Ch 28

Immunoglobulin A, HIV infection screening in infants, Ch 28

Immunoglobulin D, Ch 38

Impaired glucose tolerance (IGT), Ch 19

Inclinometer, adolescent idiopathic sco-

liosis screening, Ch 47

Indirect antiglobulin test, Ch 38

Induced abortion

chlamydial infection, Ch 29

complications, Ch 41, Ch 42

Down syndrome and, Ch 41

fetal hemoglobinopathy diagnosis, Ch 43

HIV screening, Ch 28

neural tube defects, Ch 42

sex aneuploidy, Ch 41

ultrasound examination and, Ch 36

Infants. See also Children; Newborns

asymptomatic bacteriuria, Ch 31

BCG vaccine, Ch 25

breast feeding, Ch 56

chlamydial infection, Ch 29. See also Ophthalmia neonatorum

congenital syphilis, Ch 26

feeding practices, dental caries and, 

Ch 61

hearing impairment, Ch 35

hemoglobinopathies, Ch 43

HIV infection, Ch 28

phenylketonuria, Ch 44

scoliosis, Ch 47

sickle cell disease, pneumococcal septicemia and, Ch 43

Infant safety seats, Ch 57

Infectious diseases. See also specific infections

immunizations

adult, Ch 66

childhood Ch 65

postexposure prophylaxis, Ch 67

sexually  transmitted diseases, Ch 62

Infertility

chlamydial infection, Ch 29

gonorrhea, Ch 27

Influenza A

immunization against, Ch 66

postexposure prophylaxis, Ch 66

Influenza vaccine, Ch 66

for children and adolescents, Ch 65

HIV infection and, Ch 28

Informed consent, HIV infection screening, Ch 28

Inhalants, use by children and adolescents, Ch 53

INH prophylaxis. See Isoniazid chemoprophylaxis

Injectable drugs. See Injection drug users

Injection drug users

counseling, Ch 53

hepatitis B, Ch 24

HIV infection, Ch 28

risk reduction, Ch 53

sexually  transmitted diseases, Ch 62

syphilis, Ch 26

tuberculous infection, Ch 25

Injuries

Alzheimer's disease and, Ch 48

in elderly persons, Ch 58

exercise-related, Ch 55

family violence screening and, Ch 51

household and recreational, Ch 58

motor vehicle, Ch 57

osteoporosis prophylaxis, Ch 46, Ch 58

pedestrian, Ch 57

prevention counseling, Ch 57_Ch 59

suicide risk, Ch 50

violent, Ch 51, Ch 59

Institutionalized persons. See Correctional institutions; Long-term care facilities

Instrumental Activities of Daily Living, 

Ch 48

Insulin-dependent diabetes mellitus (Type I), Ch 19. See also Diabetes mellitus

Interobserver variation, Ch ii

Intervention effectiveness, Ch ii

Interventions. See Counseling interventions; Preventive interventions, 

recommendations for

Intraobserver variation, Ch ii

Intraocular pressure, glaucoma and, Ch 34

Intrapartum electronic fetal monitoring, Ch 39

Intrauterine devices (IUDs), Ch 63

Intrauterine growth retardation

aspirin prophylaxis trials, Ch 70

maternal serum a-fetoprotein, Ch 42

ultrasonographic detection, Ch 36

Intravenous drug user. See Drug abuse; Injection drug users

Intravenous pyelography, bladder cancer and, Ch 17

IPV vaccine, Ch 65

Ipecac, syrup of, Ch 58

Iron

in healthy diet, Ch 56

iron deficiency anemia and, Ch 22

Iron deficiency anemia, Ch 22

elevated lead levels and, Ch 23

prevention and treatment. See under Iron prophylaxis

Iron prophylaxis, Ch 22, Ch 56

Ischemic heart disease. See Coronary heart disease

Isoimmunization. See D incompatibility

Isoniazid chemoprophylaxis, Ch 25

IUD (intrauterine device), Ch 63

Karyotyping, Down syndrome diagnosis, Ch 41

Kidney. See Renal entries

Labor

fetal monitoring during, Ch 39

preterm. See Home uterine activity monitoring; Premature birth

Landolt C acuity test, Ch 33

Language development, hearing impairment and, Ch 35

Latex agglutination, rubella susceptibility screening, Ch 32

Lazy eye, Ch 33

LCR. See Ligase chain reaction

LDL-C. See Low-density lipoprotein cholesterol

LE. See Leukocyte esterase

Lead, elevated blood levels, Ch 23

Lead-time bias, screening test, Ch ii

Length bias, screening test, Ch ii

Leukocyte esterase

asymptomatic bacteriuria screening, 

Ch 31

chlamydial infection screening, Ch 29

gonorrhea screening, Ch 27

Leukoplakia, oral cancer and, Ch 16

Ligase chain reaction

chlamydial infection screening, Ch 29

gonorrhea screening, Ch 27

Lip cancer, Ch 16

Lipid abnormalities, Ch 2. See also Cholesterol

carotid atherosclerosis, Ch 4

coronary heart disease, Ch 1

peripheral arterial disease, Ch 5

postmenopausal hormone prophylaxis, Ch 68

Liver. See Hepatitis entries

Long-bone length, Down syndrome, 

Ch 41

Long-term care facilities, residents

asymptomatic bacteriuria in, Ch 31

dementia in, Ch 48

hepatitis B infection in, Ch 24

injuries in, Ch 58

tuberculous infection screening in, 

Ch 25

visual impairment in, Ch 33

Low back pain, prevention counseling, Ch 60

Low birth weight

chlamydial infection, Ch 29

congenital hearing loss, Ch 35

gonorrhea, Ch 27

home uterine activity monitoring, Ch 40

iron deficiency anemia, Ch 22

maternal bacteriuria, Ch 31

maternal hemoglobin levels, Ch 22

maternal serum a-fetoprotein, Ch 42

phenylketonuria, Ch 44

preeclampsia, Ch 37

Low-density lipoprotein cholesterol. See also Cholesterol

carotid atherosclerosis and, Ch 4

Lung cancer, Ch 11

Macular degeneration, age-related, Ch 33

Magnetic resonance imaging

abdominal aortic aneurysm, Ch 6

pancreatic cancer, Ch 15

Malignant melanoma, Ch 12

Malnutrition, Ch 56

Mammography, Ch 7

Mantoux test (PPD), Ch 25

Marijuana, Ch 53

MAST (Michigan Alcoholism Screening Test), Ch 52

Maternal serum a-fetoprotein

Down syndrome, Ch 41

neural tube defects, Ch 42

Mean arterial pressure, preeclampsia, Ch 37

Mean cell volume, iron deficiency and, Ch 22

Mean corpuscular volume, thalassemia screening, Ch 43

Measles, childhood immunization. See Measles-mumps-rubella vaccine

Measles-mumps-rubella vaccine

adolescent immunization, Ch 32, Ch 65, Ch 66

adult immunization, Ch 66

in childhood, Ch 32, Ch 65

Mechanical suffocation, prevention counseling, Ch 58

Medroxyprogesterone acetate, postmenopausal hormone prophylaxis, Ch 68

Melanoma, malignant, Ch 12

Meningococcal infection, postexposure prophylaxis, Ch 67

Meningomyelocele, Ch 42

Menopause. See Postmenopause period

Menstruation

hemoglobin levels and, Ch 22

microscopic hematuria and, Ch 17

Mental health disorders. See also Depression, Suicide

exercise benefits, Ch 55

recognition and treatment, Ch 49, Ch 50

Mental retardation

congenital hypothyroidism, Ch 45

Down syndrome, Ch 41

infant phenylketonuria, Ch 44

intrapartum electronic fetal monitoring and, Ch 39

Mental status, dementia screening, Ch 48

Metabolic disorders. See also Diabetes mellitus; Obesity; Thyroid disease

dementia and, Ch 48

Methodology, preventive service evaluation, Ch ii

MHA-TP (microhemagglutination assay for antibodies to Treponema pallidum), Ch 26

Michigan Alcoholism Screening Test, 

Ch 52

Microhemagglutination assay for antibodies to Treponema pallidum, Ch 26

Military personnel

hepatitis A vaccine, Ch 66

HIV infection screening, Ch 28

rubella screening and vaccination, 

Ch 32

Mini-Mental State Examination, dementia screening, Ch 48

"Mini-pill," for contraception, Ch 63

MMR vaccine. See Measles-mumps-rubella vaccine

Modified Clinical Technique, visual impairment screening, Ch 33

Moire topography, adolescent idiopathic scoliosis screening, Ch 47

Moles, skin cancer and, Ch 12

Mono-Vacc multiple puncture test, Ch 25

Morbidity/mortality. See individual conditions

Motor vehicle injuries, Ch 57

dementia and, Ch 48

motorcycle injuries, Ch 57

visual impairment in elderly, and, Ch 33

MRI. See Magnetic resonance imaging

Multiple gestations

maternal serum a-fetoprotein, Ch 42

preeclampsia/eclampsia, Ch 37

ultrasonographic detection, Ch 36

Multiple-marker screening. See Serum markers, maternal

Multiple puncture tests, tuberculous infection screening, Ch 25

Multivitamins, neural tube defect prophylaxis, Ch 42

Mycobacterium avium complex (MAC), rifabutin prophylaxis, Ch 28

Mycobacterium tuberculosis. See Tuberculous infection

Myocardial infarction. See also Coronary heart disease

aspirin prophylaxis for, Ch 69

carotid artery stenosis and, Ch 4

Myopia, glaucoma and, Ch 34

Negative predictive value, screening test accuracy, Ch ii

Neisseria gonorrhoeae. See Gonorrhea

Neisseria meningitidis infection, postexposure prophylaxis, Ch 67

Neoplastic diseases. See specific cancer sites

Neural tube defects, Ch 42

Nevi, skin cancer and, Ch 12

Newborns. See also Infants; Perinatal morbidity/mortality

asymptomatic bacteriuria, Ch 31

breast feeding, Ch 56

chlamydial infection, Ch 29. See also Ophthalmia neonatorum

congenital rubella syndrome, Ch 32

genital herpes simplex, Ch 30

gonorrhea. See also Ophthalmia neonatorum

hearing impairment, Ch 35

hemoglobinopathies, Ch 43

hepatitis B, Ch 24

HIV infection, Ch 28

hypothyroidism, Ch 45

maternal illicit drug use, Ch 53

phenylketonuria, Ch 44

premature birth. See Premature birth

sickle cell disease, Ch 43

syphilis, Ch 26

visual impairment, Ch 33

Nicotine products, smoking cessation aid, Ch 54

Nitrite testing, asymptomatic bacteriuria screening, Ch 31

Noise-induced hearing impairment, Ch 35

Noncompliance, Ch iv

Non-insulin-dependent diabetes mellitus (Type II), Ch 19. See also Diabetes mellitus

Nuchal fold thickness, Down syndrome and, Ch 41

Nutrition, Ch 56. See also Diet therapy; Weight control

counseling, Ch 56

dental and periodontal disease risk reduction, Ch 61

iron deficiency anemia, Ch 22

lead levels and, Ch 23

neural tube defect prophylaxis, Ch 42

obesity, Ch 21

Nutritional counseling, Ch 56

Nutritional disorders. See Iron deficiency anemia; Obesity

Obesity, Ch 21

diabetes mellitus, Ch 19

endometrial cancer, Ch 64

exercise benefits, Ch 55

hypertension, Ch 3

low back pain risk, Ch 60

Occupant restraints, motor vehicle injury prevention, Ch 57

Occupational exposures

bladder cancer, Ch 17

lead levels, Ch 23

low back pain risk, Ch 60

oral cancer, Ch 16

Ocular alignment assessment, Ch 33

Ocular hypertension, Ch 34

Ocular misalignment, Ch 33

Ocular prophylaxis, neonatal. See Ophthalmia neonatorum

OGTT(oral glucose tolerance test), Ch 19

Ophthalmia neonatorum

chlamydial infection, Ch 29

gonorrhea, Ch 27

ocular prophylaxis for, Ch 27, Ch 29

Ophthalmoscopy

glaucoma screening, Ch 34

visual impairment screening, Ch 33

Opiates, Ch 53. See also Drug abuse

OPV vaccine. See Oral polio vaccine

Oral cancer, Ch 16

Oral contraceptives, Ch 63

gynecologic cancer prevention, Ch 64

Oral disease

cancer, Ch 16

prevention counseling, Ch 61

Oral glucose tolerance test, Ch 19

Oral polio vaccine

in childhood, Ch 65

HIV infection and, Ch 28

Oropharyngeal cancer, Ch 16

Orthotic devices

adolescent idiopathic scoliosis, Ch 47

low back pain prevention, Ch 60

Osteoporosis, postmenopausal

diet and, Ch 56

estrogen replacement therapy, Ch 68

exercise effects, Ch 55

injury risk, Ch 58

screening for, Ch 46

Otitis media, Ch 35

Otoacoustic emission testing, Ch 35

Otoscopy, Ch 35

Ovarian cancer, Ch 14

colorectal cancer and, Ch 8

obesity and, Ch 21

risk reduction, Ch 64

Pain, back. See Back pain

Palpation

abdominal aortic aneurysm, Ch 6

oral cancer, Ch 16

ovarian cancer, Ch 14

pancreatic cancer, Ch 15

prostate cancer, Ch 10

of pulse, peripheral arterial disease, Ch 5

testicular cancer, Ch 13

thyroid cancer, Ch 18

Pancreatic cancer, Ch 15

Papanicolaou test

cervical cancer, Ch 9

ovarian cancer, Ch 14

Pap smear. See Papanicolaou test

Partner notification. See Contact tracing

Passive smoking, Ch 54

Patient education, Ch iv. See also Counseling interventions

PCP (Pneumocystis carinii pneumonia), 

Ch 28

PCR. See Polymerase chain reaction

Pedestrian injuries, prevention counseling, Ch 57

Peer mediation, Ch 59

Pelvic examination

cervical cancer, Ch 9

chlamydial infection, Ch 29

gonorrhea, Ch 27

ovarian cancer, Ch 14

Pelvic inflammatory disease

chlamydial infection, Ch 29

gonorrhea, Ch 27

Penicillin prophylaxis in sickle cell disease, Ch 43

Pentamidine, Ch 28

Perceived-Benefit-of-Drinking scale, Ch 52

Perimetry, glaucoma screening, Ch 34

Perinatal infection transmission

chlamydial infection, Ch 29

genital herpes simplex, Ch 30

hepatitis B virus, Ch 24

human immunodeficiency virus, Ch 28

Perinatal morbidity/mortality

asphyxia, congenital hearing loss and, Ch 35

chlamydial infection and, Ch 29

chronic hypertension and, Ch 37

congenital syphilis, Ch 26

D incompatibility, Ch 38

fetal distress, Ch 39

gestational diabetes, Ch 19

home uterine activity monitoring and, Ch 40

intrapartum fetal monitoring and, 

Ch 39

maternal bacteriuria, Ch 31

maternal hemoglobin levels, Ch 22

in multiple gestation, Ch 36

neural tube defects, Ch 42

preeclampsia, Ch 37

premature birth, Ch 40

ultrasonography and, Ch 36

Periodic health examination: age-specific charts, Ch iii

Periodontal disease

nutritional factors, Ch 56

prevention counseling, Ch 61

Peripheral arterial disease, Ch 5

Pertussis, immunization against. See Diphtheria-pertussis-tetanus vaccine

Pharynx

cancer, Ch 16

gonococcal infection, Ch 27

Phenylalanine, phenylketonuria and, 

Ch 44

Phenylketonuria, Ch 44

Photon absorptiometry, osteoporosis screening, Ch 46

Physical activity, Ch 55. See also Exercise

Physical examination. See also Palpation; Self-examination

adolescent idiopathic scoliosis, Ch 47

breast cancer, Ch 7

family violence injuries, Ch 51

genital herpes simplex, Ch 30

oral cancer, Ch 16

ovarian cancer, Ch 14

skin cancer, Ch 12

PID. See Pelvic inflammatory  disease

Plethysmography, peripheral arterial disease, Ch 5

Pneumococcal disease

adult immunization, Ch 66

childhood immunization, Ch 65

sickle cell disease and, Ch 43

Pneumococcal vaccine

for adults, Ch 66

for children and adolescents, Ch 65

Pneumocystis carinii pneumonia, Ch 28

Poisoning(s)

prevention counseling, Ch 58

suicide, Ch 50

Polio vaccines, Ch 65. See also Oral polio vaccine

Polymerase chain reaction

chlamydial infection screening, Ch 29

genital herpes simplex screening, 

Ch 30

gonorrhea screening, Ch 27

HIV infection screening, Ch 28

phenylketonuria prenatal diagnosis, Ch 44

Polyps, colorectal cancer and, Ch 8

Polysaccharide (polyribosyl-ribitol phosphate) vaccine, Ch 65

Positive predictive value, screening test accuracy, Ch ii

POSIT (Problem Oriented Screening Instrument for Teenagers), Ch 52

Postexposure prophylaxis

Haemophilus influenzae type b, Ch 67

hepatitis A and B, Ch 67

influenza A, Ch 66

meningococcal infection, Ch 67

rabies, Ch 67

tetanus, Ch 67

Postmenopausal hormone prophylaxis, Ch 68

Postmenopause period

blood cholesterol elevation, Ch 2

breast cancer screening, Ch 7

hormone prophylaxis, Ch 68

osteoporosis. See Osteoporosis, postmenopausal

ovarian cancer screening, Ch 14

thyroid dysfunction, Ch 20

Postpartum period

D incompatibility prophylaxis, Ch 38

thyroid dysfunction, Ch 20

Povidone-iodine. See Ophthalmia neonatorum

PPD (tuberculin purified protein derivative), Ch 25

PPV (positive predictive value), Ch ii

Preeclampsia/eclampsia, Ch 37

aspirin prophylaxis, Ch 70

childhood asymptomatic bacteriuria and, Ch 31

diabetes mellitus and, Ch 19

Preferential looking, Ch 33

Pregnancy

alcohol use during, Ch 52

aspirin prophylaxis in, Ch 70

asymptomatic bacteriuria and, Ch 31

back pain, Ch 60

chlamydial infection and, Ch 29

D incompatibility, Ch 38

Down Syndrome, Ch 41

drug abuse. See Drug abuse

elevated lead levels and, Ch 23

genital herpes simplex and, Ch 30

gestational diabetes mellitus, Ch 19

gonorrhea and, Ch 27

hemoglobinopathies, Ch 43

hepatitis B and, Ch 24

HIV infection and, Ch 28

home uterine activity monitoring, 

Ch 40

intrapartum fetal monitoring, Ch 39

iron deficiency anemia and, Ch 22

neural tube defects, Ch 42

nutritional needs in, Ch 56

phenylketonuria, Ch 44

preeclampsia, Ch 37

rubella and, Ch 32

syphilis and, Ch 26

thyroid dysfunction and, Ch 20

ultrasonography in. See under Ultrasonography

unintended, Ch 63

Premature birth

chlamydial infection, Ch 29

hearing impairment, Ch 35

home uterine activity monitoring, 

Ch 40

maternal bacteriuria and, Ch 31

maternal diabetes mellitus and, Ch 19

maternal hemoglobin levels, Ch 22

neonatal visual impairment, Ch 33

preeclampsia and, Ch 37

Presbycusis, Ch 35

Presbyopia, Ch 33

Preterm labor, Ch 40. See also Premature birth

Preventive interventions, recommendations for

age-specific charts, Ch iii

quality of evidence, Appendix A

ratings tables, Appendix A

Problem drinking, Ch 52. See also Alcohol consumption

Problem Oriented Screening Instrument for Teenagers (POSIT), Ch 52

Progestin

contraceptives, Ch 63

postmenopausal use, Ch 68

Prophylaxis. See Immunizations; Postexposure prophylaxis; Vaccines

Prostate cancer, Ch 10

urinalysis and, Ch 17

Prostate-specific antigen, Ch 10

Prostatic acid phosphatase, Ch 10

Prostitutes

chlomydial infection, Ch 29

gonorrhea screening and, Ch 27

HIV infection and, Ch 28

syphilis and, Ch 26

PRP vaccine. See Polysaccharide (polyribosyl-ribitol phosphate) vaccine

PSA (prostate-specific antigen), Ch 10

Psychological factors

adolescent idiopathic scoliosis, Ch 47

low back pain risk, Ch 60

Pulmonary diseases. See Lung cancer; Tuberculous infection

adolescent idiopathic scoliosis and, Ch 47

Pulse, in peripheral arterial disease, Ch 5

Questions/questionnaires. See Screening questions/questionnaires

Rabies

postexposure prophylaxis, Ch 67

vaccination, Ch 67

Radiation exposure

adolescent idiopathic scoliosis screening, Ch 47

breast cancer and, Ch 7

solar

oral cancer and, Ch 16

skin cancer and, Ch 12

thyroid cancer and, Ch 18

Radiography

abdominal aortic aneurysm, Ch 6

adolescent idiopathic scoliosis, Ch 47

chest, lung cancer screening, Ch 11

skeletal, osteoporosis screening, Ch 46

Radioimmune assay

congenital hypothyroidism screening, Ch 45

illicit drug use screening, Ch 53

Radionuclide imaging, coronary heart disease, Ch 1

Random Dot E stereogram, Ch 33

Rape, Ch 51, Ch 59

Rapid plasma reagin test, Ch 26

Ratings tables, Appendix A

Recommendations. See Preventive interventions, recommendations for

Recreational injuries, prevention counseling, Ch 58. See also Injuries

Rectal examination. See Digital rectal examination

Reflux nephropathy, in children, Ch 31

Refractive errors, Ch 33

Relative risk, Ch ii

Reliability, screening test, Ch ii

Renal cancer, Ch 17

Renal scarring, asymptomatic bacteriuria and, Ch 31

13-cis-Retinoic acid, oral cancer and, 

Ch 16

Rh incompatibility, Ch 38

Rhythm method, for contraception, 

Ch 63

RIA. See Radioimmune assay

Rifampin prophylaxis

Haemophilus influenzae type b disease, Ch 67

meningococcal infection, Ch 67

tuberculous infection, Ch 25

Rimantadine, Ch 66

RPR (rapid plasma reagin) test, Ch 26

RU 486, Ch 63

Rubella, Ch 32. See also Measles-mumps-rubella vaccine

congenital hearing loss, Ch 35

neonatal visual impairment, Ch 33

RVA (rabies vaccine, adsorbed). See Rabies

Safety. See Injuries

Safety belts, Ch 57

Safety helmets

bicycle and ATV, Ch 58

motorcycle, Ch 57

Scald burns, Ch 58

Scalp blood sampling, intrapartum monitoring, Ch 39

Schiotz tonometry, Ch 34

School programs

anti-tobacco, Ch 54

pedestrian skills, Ch 57

scoliosis screening, Ch 47

sex and HIV education, Ch 62

unintended pregnancy, Ch 63

vision screening, Ch 33

Scoliosis, adolescent idiopathic, Ch 47

Screening questions/questionnaires

dementia, Ch 48

drug abuse, Ch 53

family violence, Ch 51

hearing impairment, Ch 35

lead levels, Ch 23

major depressive disorder, Ch 49

problem drinking, Ch 52

suicide risk, Ch 50

visual impairment, Ch 33

Screening tests, accuracy, Ch ii

Seat belts, Ch 57

Selection bias, Ch ii

Self-examination

breast, Ch 7

skin, Ch 12

testes, Ch 13

Self-palpation, premature birth screening, Ch 40

Self-Rating Depression Scale, Ch 49

Sensitivity, screening test, Ch ii

Sensorineural hearing deficits, Ch 35

Serologic testing

genital herpes simplex, Ch 30

rubella susceptibility screening, Ch 32

syphilis, Ch 26

Serum ferritin, Ch 22

Serum iron, Ch 22

Serum markers, maternal

Down syndrome, Ch 41

a-fetoprotein, Ch 42

multiple-marker screening, Ch 41

Serum thyroxine. See Thyroxine

Serum tumor markers

lung cancer, Ch 11

ovarian cancer, Ch 14

pancreatic cancer, Ch 15

prostate cancer, Ch 10

testicular cancer, Ch 13

Sex education, Ch 63

Sexual abstinence, Ch 63

genital herpes simplex and, Ch 30

sexually transmitted diseases and, 

Ch 62

Sexual abuse, Ch 51

Sexual activity

cervical cancer, Ch 9, Ch 64

chlamydial infection, Ch 29

genital herpes simplex, Ch 30

gonococcal infections and, Ch 27

hepatitis B risk, Ch 24

HIV screening and, Ch 28

partner notification. See Contact tracing

sexually transmitted disease and, Ch 62

syphilis screening and, Ch 26

unintended pregnancy, Ch 63

Sexually transmitted diseases (STDs), prevention counseling, Ch 62. See also specific diseases

Sickle cell disease, Ch 43

Sigmoidoscopy, Ch 8

Silver nitrate. See Ophthalmia neonatorum

Single photon absorptiometry, Ch 46

Skin cancer, Ch 12

Skinfold thickness, obesity screening, Ch 21

Slit-lamp examination, Ch 34

Smoke detectors, Ch 58

Smokeless tobacco, Ch 54. See also Tobacco use

Smoking, Ch 54. See also Tobacco use

Snellen visual acuity chart, Ch 33

Socioeconomic status, low

cervical cancer, Ch 9

chlamydial infection, Ch 29

elevated lead levels, Ch 23

gonococcal infections, Ch 27

HIV infection, Ch 28

iron deficiency anemia, Ch 22

tuberculous infection, Ch 25

Sodium, dietary, Ch 56

Sonography. See Ultrasonography

Specificity, screening test, Ch ii

Speech and language development, hearing impairment and, Ch 35

Spermicides

contraceptive method, Ch 63

sexually transmitted diseases and, Ch 62

Sphygmomanometry

blood pressure screening, Ch 3

preeclampsia/eclampsia, Ch 37

Spina bifida, Ch 42

Spouse abuse, Ch 51

Sputum cytology, lung cancer, Ch 11

Squamous cell carcinoma, Ch 12

STDs (sexually transmitted diseases), 

Ch 62

Stereoacuity testing, Ch 33

Stereoscopic photographs, glaucoma screening, Ch 34

Sterilization

female. See Tubal ligation

male, Ch 63

Stool guaiac, Ch 8

Strabismus, Ch 33

Streptococcus pneumoniae. See Pneumococcal disease

Stroke. See Cerebrovascular disease

Subdermal implants, contraceptive method, Ch 63

Substance abuse. See Alcohol consumption; Drug abuse

Suffocation, prevention counseling, Ch 58

Suicide, Ch 50

depression and, Ch 49

Sun exposure. See Radiation, solar

Sunscreens, Ch 12

Syphilis, Ch 26

congenital hearing loss and, Ch 35

dementia and, Ch 48

gonorrhea co-infection, Ch 27

HIV co-infection, Ch 26

T4. See Thyroxine

Tacrine, Ch 48

Tanning ability, skin cancer and, Ch 12

Tanning facilities, skin cancer and, Ch 12

Td (tetanus-diphtheria) vaccine, Ch 66

tetanus postexposure prophylaxis, 

Ch 67

Teenagers. See Adolescents

Teeth. See Dental disease

Teratogenic risk

acyclovir therapy for herpes simplex virus, Ch 30

maternal hyperphenylalaninemia, Ch 44

rubella vaccine, Ch 32

Testicular cancer, Ch 13

Tetanus

adult immunization, Ch 66

childhood immunization. See Diphtheria-pertussis-tetanus vaccine

postexposure prophylaxis, Ch 67

Tetanus-diphtheria (Td) vaccine, Ch 66

Tetanus immune globulin, Ch 67

Tetracycline, ocular prophylaxis, Ch 27, Ch 29

Tetrahydroaminoacridine, Ch 48

Thalassemias, Ch 43

Thallium-201 scintigraphy, Ch 1

Thermography, Ch 4

Thin-layer chromatography, Ch 53

Thin-layer isoelectric focusing, hemoglobinopathy screening, Ch 43

Thyroid antibodies, thyroid autoimmunity and, Ch 20

Thyroid cancer, Ch 18

Thyroid disease, Ch 20

cancer, Ch 18

hypothyroidism. See Hypothyroidism

Thyroid function tests, Ch 20

Thyroid-stimulating hormone

congenital hypothyroidism, Ch 45

thyroid disease/dysfunction, Ch 20

Thyrotropin-releasing hormone tests,  Ch 20

Thyroxine

congenital hypothyroidism and, Ch 45

thyroid dysfunction and, Ch 20

TIAs (transient ischemic attacks), Ch 4

Ticlopidine prophylaxis, Ch 4

Tine multiple puncture test, Ch 25

TLC (thin-layer chromatography), Ch 53

TMP-SMX (trimethoprim-sulfamethoxazole) prophylaxis, Ch 28

Tobacco use, Ch 54

abdominal aortic aneurysm, Ch 6

bladder cancer, Ch 17

blood cholesterol and, Ch 2

carotid artery stenosis, Ch 4

cervical cancer, Ch 9, Ch 64

cessation, Ch 54

coronary heart disease, Ch 1

dental and periodontal disease, Ch 61

hypertension, Ch 3

injury risk related to, Ch 58

low back pain risk, Ch 60

lung cancer, Ch 11

oral cancer, Ch 16

pancreatic cancer, Ch 15

peripheral arterial disease, Ch 5

postmenopausal osteoporosis, Ch 46

premature birth, Ch 40

prevention counseling, Ch 54

Tocodynamometry, Ch 40

Tolonium chloride rinses, Ch 16

Tongue cancer, Ch 16

Tonometry, glaucoma screening, Ch 34

Tooth brushing, Ch 61

Total-body skin examination, Ch 12

Total iron binding capacity, Ch 22

Toxemia of pregnancy. See Preeclampsia/

eclampsia

Toxoplasmosis

congenital hearing loss, Ch 35

HIV infection and, Ch 28

neonatal visual impairment, Ch 33

Transferrin saturation, iron deficiency and, Ch 22

Transient ischemic attacks, Ch 4

Transrectal ultrasound (TRUS), Ch 10

Transvaginal color-flow Doppler ultrasound, Ch 14

Treatment efficacy, screening test evaluation, Ch ii

Treponema pallidum. See Syphilis

Triglycerides, serum, Ch 2

Trimethoprim-sulfamethoxazole prophylaxis, Ch 28

Trisomy-21. See Down syndrome

TSH. See Thyroid-stimulating hormone

Tubal ligation, Ch 63

ovarian cancer risk reduction, Ch 64

Tuberculin purified protein derivative (PPD), Ch 25

Tuberculin skin testing, Ch 25

Tuberculous infection, Ch 25

BCG vaccine and, Ch 25

HIV co-infection, Ch 28

Tumbling E acuity test, Ch 33

Tumor markers. See Serum tumor markers

Tuning fork, hearing impairment screening, Ch 35

Tympanometry, Ch 35

Ultrasonography

abdominal aortic aneurysm, Ch 6

carotid artery stenosis, Ch 4

Doppler. See Doppler ultrasound

osteoporosis, Ch 46

ovarian cancer, Ch 14

pancreatic cancer, Ch 15

peripheral arterial disease, Ch 5

in pregnancy, Ch 36

Down syndrome, Ch 41

gestational age, Ch 41

isoimmunization and, Ch 38

neural tube defects, Ch 42

prostate cancer, Ch 10

thyroid cancer, Ch 18

Unconjugated estriol, Down syndrome and, Ch 41

Unintended pregnancy, counseling to prevent, Ch 63

Unintentional injuries. See also Injuries

household and recreational, Ch 58

motor vehicle, Ch 57

Urethral culture

chlamydial infection screening, Ch 29

gonorrhea screening, Ch 27

Urinalysis

asymptomatic bacteriuria, Ch 31

bladder cancer, Ch 17

chlamydial infection, Ch 29

diabetes mellitus, Ch 19

gonorrhea, Ch 27

illicit drug use, Ch 53

preeclampsia, Ch 37

in pregnancy, Ch 31

Urinary leukocyte esterase 

asymptomatic bacteriuria screening, Ch 31

chlamydial infection screening, Ch 29

gonorrhea screening, Ch 27

Urinary tract infection, Ch 31

Urine culture, asymptomatic bacteriuria, Ch 31

Urologic cancers. See Bladder cancer; Prostate cancer; Renal cancer

U.S. Preventive Services Task Force

findings, principal, Ch i

members, Ch i

periodic health examination: age-

specific charts, Ch iii

recommendations

evaluation methodology, Ch ii

ratings, Appendix A

Uterine activity monitoring. See Home uterine activity monitoring

Vaccination history, rubella susceptibility screening, Ch 32

Vaccines

diphtheria-pertussis-tetanus, Ch 65

Haemophilus influenzae type b, Ch 65

hepatitis A, Ch 66, Ch 67

in childhood, Ch 65

hepatitis B, Ch 66, Ch 67

in childhood, Ch 65

influenza, Ch 66

meningococcal, Ch 67

MMR. See Measles-mumps-rubella vaccine

pneumococcal, Ch 66

in childhood, Ch 65

polio, Ch 65

HIV infection and, Ch 28

rabies, Ch 67

rubella, Ch 32

Td series, Ch 66, Ch 67

tetanus, Ch 67

varicella, Ch 65

in adulthood, Ch 66

Vaginal sponge, Ch 62, Ch 63

Value, cost/cost-effectiveness analysis 

and, Ch v

Varicella vaccine, Ch 65

in adulthood, Ch 66

Varicella-zoster virus, immunization against. See Varicella vaccine

Vascular disease. See Cardiovascular diseases

Vasectomy, Ch 63

VDRL (Venereal Disease Research Laboratory) test, Ch 26

Vehicle injuries, prevention counseling, Ch 57

Venereal Disease Research Laboratory  (VDRL) test, Ch 26

Vertical transmission of infection. See Perinatal infection transmission

Violence

within family, Ch 51

youth prevention counseling, Ch 59

Viral culture

genital herpes simplex, Ch 30

human immunodeficiency virus, Ch 28

Visual acuity assessment. See Visual impairment

Visual field examination, glaucoma screening, Ch 34

Visual impairment, Ch 33. See also Blindness; Glaucoma

cataracts, Ch33

genital herpes simplex and, Ch 30

hip fracture risk factor, Ch 58

Vitamin B12

dementia and, Ch 48

folic acid masking, Ch 42

neural tube defect prophylaxis, Ch 42

Vitamin C, cervical cancer risk reduction, Ch 64

Vitamin D, osteoporosis prophylaxis, 

Ch 46

Waist/hip circumference ratio, obesity screening, Ch 21

Water fluoridation, Ch 61

Weight control

antihypertensive therapy, Ch 3

counseling for, Ch 21

diabetes mellitus, Ch 19

diet, healthy, Ch 56

high blood cholesterol, Ch 2

obesity, Ch 21

peripheral arterial disease, Ch 5

Weight measurement, Ch 21

Western blot analysis, HIV infection screening, Ch 28

Whispered voice testing, Ch 35

Whooping cough, childhood immunization. See Diphtheria-pertussis-tetanus vaccine

Withdrawal method, for contraception, Ch 63

X-ray. See Radiography

Young adults. See Adolescents and young adults

Youth violence, prevention counseling, Ch 59

ZDV (zidovudine), Ch 28

Zinc protoporphyrin levels, Ch 23

Zung Self-Rating Depression Scale, Ch 49